Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Capital Expenditures (2019 - 2025)

AdaptHealth (AHCO) has 7 years of Capital Expenditures data on record, last reported at $4.5 million in Q4 2025.

  • For Q4 2025, Capital Expenditures rose 102.59% year-over-year to $4.5 million; the TTM value through Dec 2025 reached $65.9 million, up 17.41%, while the annual FY2025 figure was $65.9 million, 17.41% up from the prior year.
  • Capital Expenditures reached $4.5 million in Q4 2025 per AHCO's latest filing, up from $2.3 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $340.6 million in Q4 2022 and bottomed at -$172.6 million in Q4 2024.
  • Average Capital Expenditures over 5 years is $43.2 million, with a median of $30.6 million recorded in 2022.
  • Peak YoY movement for Capital Expenditures: tumbled 843.16% in 2021, then soared 13920.35% in 2022.
  • A 5-year view of Capital Expenditures shows it stood at -$125.8 million in 2021, then skyrocketed by 370.82% to $340.6 million in 2022, then tumbled by 73.97% to $88.6 million in 2023, then crashed by 294.7% to -$172.6 million in 2024, then skyrocketed by 102.59% to $4.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $4.5 million in Q4 2025, $2.3 million in Q3 2025, and $920000.0 in Q2 2025.